Global medical radioisotopes market to be valued at $1.38b by 2034

Thanks to rising applications in diagnostics and therapeutics.

The global medical radioisotopes market is expected to reach approximately $1.37b by 2034 at a compound annual growth rate of 6.34%, according to Custom Market Insights.

The sector’s expansion is attributed to the rising applications in diagnostics and therapeutics, the increasing incidence of chronic diseases, and the growing demand across nuclear medicine.

In addition, expanding nuclear medicine infrastructure, increasing government investments, and developments in technology are driving market growth.

“The increasing demand for personalised medicine is creating new opportunities for medical radioisotopes, especially theragnostic applications that combine diagnosis and therapy,” the report said.